ClinConnect ClinConnect Logo
Search / Trial NCT02980354

Bayraktutan Dunhill Medical Trust EPC Study

Launched by UNIVERSITY OF NOTTINGHAM · Nov 29, 2016

Trial Information

Current as of May 30, 2025

Unknown status

Keywords

Endothelial Progenitor Cells, Ischaemic Stroke, Aging

ClinConnect Summary

Ischaemic stroke develops through an interference with blood supply to the brain and continues to be one of the leading causes of morbidity and mortality in the World. Global medical statistics reveal that \~75% of all stroke patients are older than 65 years and that the stroke occurrence more than doubles every 10 years after the age of 55 in both men and women.

Although various mechanisms may alter the structure and function of the adult brain during the aging process, endothelial dysfunction is regarded as the main pathology that renders cerebral vessels susceptible to atherosclerosis a...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * Participants with Stroke:
  • Patients with anterior circulation IS and aged 65 years or older. Independence prior to stroke (mRS\<3). Ability to give informed consent (directly or via consultee).
  • Age Matched Controls (Healthy Volunteers) Individuals aged 65 years or above. No previous history of stroke. Ability to give consent to take part in the study.
  • Young Healthy Volunteers Individuals aged between 18 to 64 years of age. No previous history of stroke. Ability to give consent to take part in the study.
  • Exclusion Criteria:
  • * Participants with Stroke:
  • Patients with posterior circulation IS and aged below 65 years of age. Patients with recent recurrent IS. Patients with transient ischaemic attack or IS within the last 3 months. Patients with primary intracerebral haemorrhage.
  • Age Matched Controls (Healthy Volunteers) Individuals aged below 65 years of age. Previous history of stroke.
  • * Young Healthy Volunteers (18-64):
  • Individuals aged below 18 years or are 65 years of age or above. Previous history of stroke.

About University Of Nottingham

The University of Nottingham is a leading research institution renowned for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge research and expert faculty to address pressing medical challenges. Through its dedicated clinical trials unit, the University of Nottingham conducts rigorous studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. The institution prioritizes ethical practices and participant safety, ensuring that all trials are designed to uphold the highest standards of scientific integrity and regulatory compliance.

Locations

Nottingham, , United Kingdom

Nottingham, , United Kingdom

Patients applied

0 patients applied

Trial Officials

Ulvi Bayraktutan, PhD

Principal Investigator

University of Nottingham

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials